Scientists test if common surgery drug reaches unborn babies
NCT ID NCT06634355
Summary
This study aims to find out if a drug called sugammadex, used to reverse muscle relaxants after surgery, can cross the human placenta and reach a developing fetus. Researchers will use donated placentas from healthy pregnancies in a lab model to measure drug transfer. The goal is to gather critical safety information for pregnant women who might need this medication during surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
Conditions
Explore the condition pages connected to this study.